‘Charming Kitten’ believed to be a front for Islamic Revolutionary Guard Corps, according to HHS’ cybersecurity agency.
Hackers from Iran could pose the next threat to physician and hospital computer networks.
“Iranian Threat Actors & Healthcare” is the latest threat brief by the Health Sector Cybersecurity Coordination Center (HC3) within the U.S. Department of Health and Human Services. HC3 periodically publishes the briefs and other information about relevant cybersecurity topics to raise awareness of current threats, threat actors, best practices, and tactics to avoid cyberattacks.
Iran is historically a “risk-averse actor,” but online attacks provide “a means to exploit enemy vulnerabilities while minimizing the risk of escalation/retaliation,” according to HC3. Iranian hackers have engaged in website defacement, spear phishing, distributed denial-of-service attacks, theft of personally identifiable information, installation of malware, and social media-driven operations.
In 2021, Iran also signed cooperation agreements that focus on cybersecurity and information and communication technology with Russian, and establishing a 25-year economic and defense collaboration with China, according to HC3. The countries share some common goals including greater censorship.
Advertisement
To avoid cyberattacks, HC3 recommended the measures such as:
The threat actor “Charming Kitten” is associated with the Islamic Revolutionary Guard Corps (IRGC), according to HC3. That group formed “as an ideological custodian of Iran’s 1979 revolution.” In April 2019, President Donald J. Trump designated it a foreign terrorist organization, the first state security agency to receive that designation, according to the Council on Foreign Relations.
Charming Kitten, also known as TA453, Cobalt Illusion, Magic Hound, ITG18, Phosphorus, Newscaster, or APT35, has targeted medical researchers, dissidents, diplomats, human rights activists, media, government, military, energy, and telecommunications operations.
The group has used spear phishing, or targeted phony emails that attempt to fool receivers into revealing confidential information. Other tactics include leveraging fake personas and social media platforms to interact with targets and impersonating popular online sites to harvest user credentials, according to HC3, which listed at least eight other hacking handles, including six that use “kitten” in the name.
The IRGC also was the subject of a multinational cybersecurity advisory published in September by the National Security Agency and American allies.
In the United States, Iranian hackers are associated with a thwarted cyberattack on a children’s hospital and a Facebook campaign targeting Americans and Europeans. In that campaign, hackers pretended to work in hospitality, medicine, journalism, nongovernmental organizations, and at airlines, according to HC3.
Things were worse for the government of Albania. That country has the headquarters of the Iranian group PMOI/MEK, which opposes the ruling regime in Iran, and was the location for the World Summit of Free Iran conference July 23-24, 2022.
The Albanian government faced a two-phase cyberattack that started about 14 months before July 18, 2022, when the “government published a statement announcing that it had to ‘temporarily close access to online public services and other government websites’ due to disruptive cyber activity,” according to HC3.
This article originally appeared on Medical Economics®.
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More